Nellore, India

Anandam Vempali

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Anandam Vempali

Introduction

Anandam Vempali is a notable inventor based in Nellore, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of various compounds. With a total of 2 patents to his name, his work has the potential to impact the medical industry positively.

Latest Patents

Anandam Vempali's latest patents include a process for the preparation of crystalline Form I of methanesulfonate salt of dabigatran etexilate. This invention relates to a method that does not require the isolation of the dabigatran etexilate intermediate, streamlining the production process. Another significant patent involves the preparation of erlotinib or its pharmaceutically acceptable salts. This invention encompasses the preparation of erlotinib trifluoroacetate and introduces a novel crystalline form of erlotinib trifluoroacetate designated as Form E, along with the process for its preparation.

Career Highlights

Anandam Vempali is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate and contribute to pharmaceutical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Balaguru Murugesan and Swargam Sathyanarayana. Their collective expertise enhances the innovative environment at Ranbaxy Laboratories.

Conclusion

Anandam Vempali's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His patents reflect a dedication to improving drug preparation processes, which can lead to more effective treatments for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…